Biblio
Export 232 results:
Author Title Type [ Year
Filters: First Letter Of Keyword is E [Clear All Filters]
“Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities.”, J Alzheimers Dis, vol. 91, no. 1, pp. 495-506, 2023.
, “Linking Air Pollution Exposure to Blood-Based Metabolic Features in a Community-Based Aging Cohort with and without Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1025-1040, 2023.
, “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
, “Mediation Effect of Brain Volume on the Relationship Between Peripheral Inflammation and Cognitive Decline.”, J Alzheimers Dis, vol. 95, no. 2, pp. 523-533, 2023.
, “Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1607-1615, 2023.
, “Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
, “Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES.”, J Alzheimers Dis, vol. 92, no. 2, pp. 487-498, 2023.
, “Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy.”, J Alzheimers Dis, vol. 94, no. s1, pp. S253-S265, 2023.
, “Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.”, J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
, “Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?”, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
, “Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?”, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
, “PM2.5 and Dementia in a Low Exposure Setting: The Influence of Odor Identification Ability and APOE.”, J Alzheimers Dis, vol. 92, no. 2, pp. 679-689, 2023.
, “5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 573-585, 2022.
, “Better Subjective Sleep Quality Partly Explains the Association Between Self-Reported Physical Activity and Better Cognitive Function.”, J Alzheimers Dis, vol. 87, no. 2, pp. 919-931, 2022.
, “Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 893-901, 2022.
, “Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study.”, J Alzheimers Dis, vol. 88, no. 3, pp. 893-901, 2022.
, “Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.”, J Alzheimers Dis, vol. 85, no. 3, pp. 975-992, 2022.
, “Alzheimer's Disease and Face Masks in Times of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
, “Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.”, J Alzheimers Dis, vol. 80, no. 2, pp. 749-759, 2021.
, “Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.”, J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
, “Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.”, J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
, “Dementia-Friendly "Design": Impact on COVID-19 Death Rates in Long-Term Care Facilities Around the World.”, J Alzheimers Dis, vol. 81, no. 2, pp. 427-450, 2021.
, “Is the Frontal Lobe the Primary Target of SARS-CoV-2?”, J Alzheimers Dis, vol. 81, no. 1, pp. 75-81, 2021.
, “Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 82, no. s1, pp. S109-S126, 2021.
, “An Introduction to Ultrasensitive Assays for Plasma Tau Detection.”, J Alzheimers Dis, vol. 80, no. 4, pp. 1353-1362, 2021.
,